Ines Meyer is currently the Head of Due Diligence at Sandoz Biopharmaceuticals, a position held since 2018. Previously, Ines served as a Global Program Team Director at Novartis Oncology from 2013 to 2016 and held several roles in biostatistics and project leadership at companies including MediGene AG and GE Healthcare Bio-Sciences from 2002 to 2009. Earlier in their career, Ines worked as an Epidemiologist at Helmholtz Zentrum Munich from 1997 to 2002.
This person is not in the org chart
This person is not in any teams
This person is not in any offices